These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1404436)

  • 1. Importance of pharmacologic considerations in the evaluation of new treatments for acute spinal cord injury.
    Hall ED
    J Neurotrauma; 1992; 9(2):173-5; discussion 175-6. PubMed ID: 1404436
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylprednisolone use in acute spinal cord injury.
    Acland RH; Anthony A; Inglis GS; Walton DI; Xiong X
    N Z Med J; 2001 Mar; 114(1127):99. PubMed ID: 11297147
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology and pharmacologic treatment of acute spinal cord injury.
    Kwon BK; Tetzlaff W; Grauer JN; Beiner J; Vaccaro AR
    Spine J; 2004; 4(4):451-64. PubMed ID: 15246307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for the development of new and better pharmacological treatments for acute spinal cord injury.
    Young W
    Adv Neurol; 1993; 59():249-56. PubMed ID: 8420109
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylprednisolone in acute spinal cord injury: a tarnished standard.
    Miller SM
    J Neurosurg Anesthesiol; 2008 Apr; 20(2):140-2. PubMed ID: 18362778
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose methylprednisolone may do more harm for spinal cord injury.
    Qian T; Campagnolo D; Kirshblum S
    Med Hypotheses; 2000 Nov; 55(5):452-3. PubMed ID: 11058428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic strategies in the treatment of experimental spinal cord injury.
    Nockels R; Young W
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S211-7. PubMed ID: 1588610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
    Casha S; Zygun D; McGowan MD; Bains I; Yong VW; Hurlbert RJ
    Brain; 2012 Apr; 135(Pt 4):1224-36. PubMed ID: 22505632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone.
    Young W; DeCrescito V; Flamm ES; Blight AR; Gruner JA
    Clin Neurosurg; 1988; 34():675-97. PubMed ID: 3378379
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary injury mechanisms in acute spinal cord injury.
    Young W
    J Emerg Med; 1993; 11 Suppl 1():13-22. PubMed ID: 8445198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose methylprednisolone in the treatment of spinal cord injuries.
    Hilton G; Frei J
    Heart Lung; 1991 Nov; 20(6):675-80. PubMed ID: 1960072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End organ effects of high-dose human equivalent methylprednisolone in a spinal cord injury rat model.
    Kubeck JP; Merola A; Mathur S; Brkaric M; Majid K; Shanti N; Caruso S; Yuan S; Lowe T; Dwyer A; Haher T; O'Brien M
    Spine (Phila Pa 1976); 2006 Feb; 31(3):257-61. PubMed ID: 16449896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized dosing tables to reduce errors involving high-dose methylprednisolone for acute spinal cord injury.
    Lesar TS
    Hosp Pharm; 1994 Oct; 29(10):935-6, 938. PubMed ID: 10137851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the use of the methylprednisolone protocol for traumatic spinal cord injury in Switzerland.
    Felleiter P; Müller N; Schumann F; Felix O; Lierz P
    Spine (Phila Pa 1976); 2012 May; 37(11):953-6. PubMed ID: 22020592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Collins WF; Holford TR; Young W; Baskin DS; Eisenberg HM; Flamm E; Leo-Summers L; Maroon J
    N Engl J Med; 1990 May; 322(20):1405-11. PubMed ID: 2278545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current role of methylprednisolone in the treatment of acute spinal cord injury].
    Lukáš R; Zýková I; Barsa P; Srám J
    Acta Chir Orthop Traumatol Cech; 2011; 78(4):305-13. PubMed ID: 21888840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The early protective effects of L-arginine and Ng-nitro-L-arginine methyl ester after experimental acute spinal cord injury. A light and electron microscopic study.
    Yüceer N; Attar A; Sargon MF; Egemen N; Türker RK; Demirel E
    J Clin Neurosci; 2000 May; 7(3):238-43. PubMed ID: 10833623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methylprednisolone in acute spinal cord injuries: proceed with caution.
    Pandya KA; Weant KA; Cook AM
    Orthopedics; 2010 May; 33(5):327-31. PubMed ID: 20507035
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential benefits of high-dose methylprednisolone in acute spinal cord injuries.
    Walsh KA; Weant KA; Cook AM
    Orthopedics; 2010 Apr; 33(4):249-52. PubMed ID: 20415351
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-dependent effects of naloxone and methylprednisolone in the ventral compression model of spinal cord injury.
    Benzel EC; Hoffpauir GM; Thomas MM; Beal JA; Lancon JA; Kesterson L
    J Spinal Disord; 1990 Dec; 3(4):339-44. PubMed ID: 2134448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.